Joan Seoane

发表

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

Alejandra Bruna, J. Mora, J. Baselga, 2007, Cancer cell.

Patient-derived xenograft models: an emerging platform for translational cancer research.

Manuel Hidalgo, Eva Budinská, Carlos Caldas, 2014, Cancer discovery.

OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways

J. Massagué, J. Seoane, A. Hata, 2000, Cell.

Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts

Hans Clevers, Manuel Hidalgo, Eva Budinská, 2017, Nature Reviews Cancer.

A FoxO–Smad synexpression group in human keratinocytes

Wei He, Alex Lash, Roger R. Gomis, 2006, Proceedings of the National Academy of Sciences.

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

Jorge S. Reis-Filho, Josep Tabernero, J. Reis-Filho, 2013, Nature Reviews Clinical Oncology.

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Hans Clevers, Manuel Hidalgo, Eva Budinská, 2017, Nature Reviews Cancer.

Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

Violeta Serra, Maurizio Scaltriti, René Bernards, 2008, Cancer research.

New approach to cancer therapy based on a molecularly defined cancer classification

J. Seoane, A. Vivancos, J. Cortés, 2014, CA: a cancer journal for clinicians.

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Salvatore Piscuoglio, Xavier de la Cruz, Jordi Rodon, 2015, Nature Communications.

Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation

S. Anderson, J. Massagué, J. Seoane, 2004, Cell.

Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

J. Massagué, J. Seoane, H. Le, 2002, Nature.

TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

J. Massagué, J. Seoane, M. Eilers, 2001, Nature Cell Biology.

TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.

David García-Dorado, Juan Sahuquillo, Ignasi Barba, 2009, Cancer cell.

Opposite Smad and Chicken Ovalbumin Upstream Promoter Transcription Factor Inputs in the Regulation of the Collagen VII Gene Promoter by Transforming Growth Factor-β*

J. Massagué, J. Seoane, Joan Massagué, 2004, Journal of Biological Chemistry.

Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.

Jordi Teixidó, Bonaventura Clotet, José I Borrell, 2012, Journal of medicinal chemistry.